Answers are grounded in this paper and cite their sources.
The standard treatment for locally advanced rectal cancer has become is neoadjuvant chemoradiation followed by radical proctectomy with total mesorectal excision. A significant percentage of patients exhibit a pathological complete response with associated survival benefit. The management of patients who exhibit a complete clinical response after neoadjuvant chemoradiation, and could potentially avoid major resection, is a topic of great interest in colorectal surgery today. This paper reviews treatment options for this population.
No takes yet. Share an insight, caveat, or question.
Scully et al. (2017) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: